Skip to main content

Year: 2020

QuestCap Announces Planned Name Change to Medi-Volve Along With Transition to Single Purpose Medical Company

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (NEO:QSC; OTC:COPRF; FRA:34C1), is pleased to announce that it has initiated the process to change its corporate name to Medi-Volve in conjunction with its transition to a single purpose medical company, previously announced on October 13th, 2020. This name change is intended to emphasize the Company’s growth in the COVID-19 medical space and demonstrate the Company’s commitment to investing in innovative medical solutions that will combat the pandemic and help restore reality responsibly.QuestCap has assembled a management team and advisory group of renowned medical experts. This team includes Dr. Lawrence Steinman, Professor of Neurology, Neurological Sciences and Paediatrics at Stanford University and former head of Immunology at Stanford. As...

Continue reading

Revival Gold Delivers Solid Phase One Preliminary Economic Assessment

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a growth‐focused gold exploration and development company, is pleased to announce positive results from a Preliminary Economic Assessment (“PEA”) on the Company’s Beartrack-Arnett (“Beartrack-Arnett”) phase one heap leach gold project located in Idaho, USA.Beartrack-Arnett Phase One Heap Leach Gold Project – PEA Highlights*Production of 72,000 ounces of gold per year for a total of 506,000 ounces of gold over an initial seven-year mine life;Pre-production capital of $100 million and life-of-mine (“LOM”) sustaining capital of $61 million;Total cash cost of $809 per ounce and all in sustaining cost of $1,057 per ounce of gold;After-tax NPV at a 5% discount rate (“NPV5%”) of $88 million and after-tax IRR of...

Continue reading

General Counsel Report from FTI Consulting and Relativity Illustrates ‘Infinitely Expanding’ Role of Corporate Legal Departments in Turbulent Times

WASHINGTON, Nov. 17, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced findings from its Technology segment’s second annual study of corporate legal departments, in partnership with Relativity. Based on a detailed survey and one-on-one interviews by Ari Kaplan with chief legal officers at companies of all sizes, The General Counsel Report 2021: Rising to Today’s Challenges and Building Resilience for the Future, outlines the elevated responsibilities general counsel have taken on amid the pandemic and current social climate.Notably, the majority of respondents indicated moderate to significant difficulties in navigating today’s top challenges, including widely dispersed workforces, emerging data types, technology adoption and tackling diversity, equity and inclusion. The report shares the strategies counsel...

Continue reading

CloudMD to Present at Upcoming Investor Conferences

VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company seeking to revolutionize the delivery of healthcare to patients, is pleased to announce that executives from the Company’s management team will be participating in the following upcoming investor conferences:Canaccord Genuity Health and Wellness Virtual Conference, November 23, 2020Dr. Essam Hamza, CEO, will be participating in the Digital Health and Telemedicine Panel at 9 a.m. ESTKaren Adams, Chief Health Innovation Officer, will be participating in the Mental Health Services Panel at 11a.m. ESTTo register for this virtual conference, please contact your Canaccord representative.Desjardins Digital Healthcare Conference, November 24, 2020Dr....

Continue reading

AnalytixInsight’s MarketWall Launches MarketWall Lite and Enables Virtual Trading

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Artificial Intelligence company, AnalytixInsight Inc. (“AnalytixInsight”, or the “Company”) (TSX-V: ALY; OTCQB: ATIXF), announces that its FinTech affiliate, MarketWall, has recently launched several new updates available to users of its financial portal MarketWall.com as it prepares its European online financial broker, InvestoPro.MarketWall Lite is now available as a Progressive Web App (PWA). PWAs function like web browsers with the convenience of an app-like format that can be downloaded to the home screen of any device (desktop, mobile, tablet) for quick access. PWAs require less memory space and data usage compared to native apps while offering quicker load times and the ability to use certain features when offline.Virtual Trading allows users to buy or sell stocks using a virtual...

Continue reading

Verrica Pharmaceuticals Announces Receipt of Final FDA Minutes Following Type A Meeting Regarding Resubmission of the NDA for VP-102 in Molluscum

WEST CHESTER, Penn., Nov. 17, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it has received the final meeting minutes from the U.S. Food and Drug Administration (FDA) following the Company’s recent Type A meeting to discuss the steps required for resubmission of the New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum).VP-102 is a first-in-class, proprietary drug-device combination for the treatment of molluscum, a viral skin disease affecting approximately six million people, primarily children, in the United States. There are currently no FDA-approved treatments for molluscum. In July, the Company announced that it had received...

Continue reading

Progenity to Present at 2020 San Antonio Breast Cancer Virtual Symposium

SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020.The data presented will be a part of the event’s Spotlight Session Poster Presenters. Details of the presentation are as follows:Title – Describing the cancer spectrum in families with CHEK2 pathogenic and likely pathogenic variants by mutation typeAuthors – Julia G Moroney, MS, CGC, and Michele S. Basiliere, MS, CGCPoster number – PS8-18Date and time – Wednesday, December 9, 2020: 8:00 AM CTSABCS anticipates publishing abstracts in late November 2020 and posters on December 9, 2020. The poster...

Continue reading

[2020-2027] Holter ECG Market Size, Share, Trends, Growth, Analysis, Competitive Landscape, Revenue, Growth Factors, Forecast

Pune, India, Nov. 17, 2020 (GLOBE NEWSWIRE) — The global holter ECG market size will rise at a considerable pace driven recent technological advancements. The increasing applications of holter ECG across the healthcare industry will emerge in favor of market growth. According to a report by Fortune Business Insights. The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global market and discusses how major companies are coping with this. North America to Emerge Dominant; Increasing Geriatric Population will Aid Market GrowthIndustry Developments:May 2018: Preventice...

Continue reading

Compass Gold Announces Proposed Warrant Extension

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Compass Gold Corp. (TSX-V: CVB) (Compass or the Company) announces that has filed with the TSX Venture Exchange (the “Exchange”) to extend the term of certain issued and outstanding warrants that are otherwise scheduled to expire on November 29, 2020. Subject to final approval of the Exchange, the Company plans to extend the term of issued and outstanding warrants (the “Warrants”) that were issued as part of a private placement that closed on November 29, 2017 and exercisable at a price of $0.75 per share for a total of 12,200,000 common shares. None of the warrants issued in that private placement have been exercised. The proposed new expiry date for the Warrants would be November 29, 2021.About Compass Gold Corp.Compass, a public company having been incorporated...

Continue reading

Todos Medical Announces Clinical Validation and National CLIA Certification for MOTO+PARA Mobile High Complexity Labs

NEW YORK, NY, TAMPA, FL and BATON ROUGE, LA, Nov. 17, 2020 (GLOBE NEWSWIRE) — via NewMediaWire —Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced the completion of clinical validation and CLIA certification for MOTO+PARA’s mobile lab. The Company’s mobile CLIA lab partner, Integrated Health LLC, has fully validated the clinical performance of the proprietary COVID-19 RT-PCR laboratory testing process performed in MOTO+PARA’s Mobile High Complexity Labs built to biosafety level 3 (BSL3), and has received the approval needed to begin offering COVID-19 screening and analysis as a service to clients anywhere in the United States....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.